首页 | 本学科首页   官方微博 | 高级检索  
     

趋化因子受体CCR7在骨肉瘤组织中的表达和临床意义
引用本文:张弘韬,王猛,陈观印,颜世举,马琼,刘云燕,艳华,马保安. 趋化因子受体CCR7在骨肉瘤组织中的表达和临床意义[J]. 现代肿瘤医学, 2016, 0(17): 2772-2774. DOI: 10.3969/j.issn.1672-4992.2016.17.029
作者姓名:张弘韬  王猛  陈观印  颜世举  马琼  刘云燕  艳华  马保安
作者单位:第四军医大学唐都医院骨科·全军骨科中心暨骨肿瘤研究所,陕西 西安 710038
基金项目:国家自然科学基金(编号81201633)
摘    要:目的:研究 CCR7在人骨肉瘤组织中的表达情况,并探讨 CCR7表达与临床病理之间的关系。方法:收集临床50例骨肉瘤组织及20例骨软骨瘤组织,使用免疫组织化学方法检测其 CCR7的表达水平。结果:CCR7在骨肉瘤组织和骨软骨瘤组织中的阳性表达率分别为80.00%和15.00%。CCR7阳性表达和骨肉瘤肿瘤大小及转移密切相关(P <0.05),而与年龄、性别、临床分期及组织学分型没有明显关系(P >0.05)。结论:骨肉瘤组织中 CCR7高表达预示着其在肿瘤增长和肿瘤转移可能起到一定的作用。因此 CCR7可能会成为临床上治疗骨肉瘤一个新的靶点。

关 键 词:趋化因子受体7  骨肉瘤  增殖  转移

Expression of CCR7 in osteosarcoma and its clinical significance
Abstract:Objective:To investigate the expression of CCR7 in osteosarcoma and discuss the underlying relation-ship between the expression and clinical significance.Methods:Immunohistochemical staining was used to measure the expression of CCR7 in 50 cases of osteosarcoma tissues and 20 cases of osteochondroma tissues.Results:The posi-tive expression rates of CCR7 were 80.00% and 15.00% respectively in 50 cases of osteosarcoma tissues and 20 ca-ses of osteochondroma tissues.The CCR7 expression were related to the size of the tumor(P <0.05)and the metasta-sis of osteosarcoma(P <0.05).There was no evident link between CCR7 expression and age,gender,clinical stages and histological type(P >0.05).Conclusion:The highly expressed CCR7 in osteosacroma indicates that CCR7 may play a significant role in tumor progression and metastasis.Therefore,CCR7 could be an ideal target for the treatment of osteosarcoma.
Keywords:CCR7  osteosarcoma  proliferation  metastasis
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号